Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
JAMA Dermatology|January 9, 2020
Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During PregnancyNiklas Worm Andersson, Jon Trærup Andersen
British Journal of Clinical Pharmacology|June 1, 2026
Methyldopa and the risk of peripartum depression-A nationwide registry-based studyJoachim Hjalde Halmsted Olsen, Jon Trærup Andersen
Rheumatology (Oxford, England)|November 24, 2020
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort studyNiklas Worm Andersson, Lone Skov, Jon Trærup Andersen
JAMA Dermatology|March 5, 2020
Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous AbortionNiklas Worm Andersson, Simon Francis Thomsen, Jon Trærup Andersen
JAMA Pediatrics|June 2, 2020
Association Between Fexofenadine Use During Pregnancy and Fetal OutcomesNiklas Worm Andersson, Christian Torp-Pedersen, Jon Trærup Andersen
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
Desloratadine Use During Pregnancy and Risk of Adverse Fetal Outcomes: A Nationwide Cohort StudyNiklas Worm Andersson, Henrik Enghusen Poulsen, Jon Trærup Andersen
BMJ (Clinical Research Ed.)|February 11, 2021
Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort studyNiklas Worm Andersson, Rasmus Huan Olsen, Jon Trærup Andersen
Obstetrics and Gynecology|March 10, 2017
Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before PregnancyLasse Karlsen Eck, Thomas Bo Jensen, Dimitrios Mastrogiannis, et al.
Drug and Alcohol Dependence|August 18, 2019
Anabolic-androgenic steroids and the risk of imprisonmentThea Christoffersen, Jon Trærup Andersen, Kim Peder Dalhoff, et al.
Pageof 8